With over a century of experience and an unrivaled team of experts, Kindeva Drug Delivery has the drug delivery technology know-how and manufacturing capabilities to bring your therapy to market faster. We manage every portion of your needs in-house, saving you time and money while reducing your carbon footprint.
Pulmonary
As a global CDMO leader in drug-device combination products, Kindeva Drug Delivery supports pharma and biotech clients with the development and manufacturing of a full spectrum of pulmonary drug delivery products for respiratory and systemic diseases. Our expertise includes generics, new chemical entities, and reformulations, and we are leading the way in green propellants. Clinical supply for HFA152a and HFO1234ze is available now at our Loughborough, U.K., facility, with commercial scale available this year.
Nasal
We offer full-service CDMO support for intranasal administration, with horizontal and vertical integration. This includes an on-site laboratory, unmatched manufacturing capabilities for unit-dose and bi-dose nasal drug delivery technology. Backed by a legacy of product approvals across the U.S. and European markets, we help you bring your therapy to the world.
Injectables
Through our St. Louis facilities, we combine device manufacture, sterile fill-finish, and final assembly in one geographic location, simplifying your supply chain. From clinical to niche commercial and large-scale commercial manufacturing, Kindeva can support all your injectable needs in-house. We invented the first autoinjector and in the 60 years since this innovation, we have continued to develop and manufacture new platforms that deliver outstanding reliability and quality, as well as working with third-party platforms.
Microneedle array patches
Across small and large molecules including vaccines, peptides, proteins, and biologics, our microneedle array patch platforms could deliver broad-reaching benefits, including the potential to eliminate cold chain storage. With capabilities to produce ~14 million patches per year for commercial manufacturing and over 1 million patches for clinical trials, our capacity scales with your therapy.
Transdermal
From patches to pharmaceutical- and medical-grade GMP coating capabilities to tech transfers, our transdermal drug-delivery technologies impact positive health outcomes all over the globe. When you need a proven innovator with a history of launching next-generation drug-delivery systems, combine forces with Kindeva.